Six action steps to address global disparities in parkinson disease: A world health organization priority

• Main Authors: Schiess, Nicoline, Cataldi, Rodrigo, Okun, Michael S., Fothergill-Misbah, Natasha, Dorsey, E. Ray, Bloem, Bastiaan R., Barretto, Maria, Bhidayasiri, Roongroj, Brown, Richard, Chishimba, Lorraine, Chowdhary, Neerja, Coslov, Max, Cubo, Esther, Di Rocco, Alessandro, Dolhun, Rachel, Dowrick, Christopher, Fung, Victor S. C., Gershanik, Oscar S., Gifford, Larry, Gordon, Joyce, Khalil, Hanan, Kuehn, Andrea A., Lew, Sara, Lim, Shen-Yang, Marano, Maria M., Micallef, Jacquie, Mokaya, Jolynne, Moukheiber, Emile, Nwabuobi, Lynda, Okubadejo, Njideka, Pal, Pramod Kumar, Shah, Hiral, Shalash, Ali, Sherer, Todd, Siddiqui, Bernadette, Thompson, Ted, Ullrich, Andreas, Walker, Richard, Dua, Tarun
• Format: Article
• Published: Amer Medical Assoc 2022
• Subjects: RC Internal medicine
• Online Access: http://eprints.um.edu.my/41420/
• Institution: Universiti Malaya

IMPORTANCE The Global Burden of Disease study conducted between 1990 and 2016, based on a global study of 195 countries and territories, identified Parkinson disease (PD) as the fastest growing neurological disorder when measured using death and disability. Most people affected by PD live in low- and middle-income countries (LMICs) and experience large inequalities in access to neurological care and essential medicines. This Special Communication describes 6 actions steps that are urgently needed to address global disparities in PD. OBSERVATIONS The adoption by the 73rd World Health Assembly (WHA) of resolution 73.10 to develop an intersectoral global action plan on epilepsy and other neurological disorders in consultation with member states was the stimulus to coordinate efforts and leverage momentum to advance the agenda of neurological conditions, such as PD. In April 2021, the Brain Health Unit at the World Health Organization convened a multidisciplinary, sex-balanced, international consultation workshop, which identified 6 workable avenues for action within the domains of disease burden; advocacy and awareness; prevention and risk reduction; diagnosis, treatment, and care; caregiver support; and research. CONCLUSIONS AND RELEVANCE The dramatic increase of PD cases in many world regions and the potential costs of PD-associated treatment will need to be addressed to prevent possible health service strain. Across the board, governments, multilateral agencies, donors, public health organizations, and health care professionals constitute potential stakeholders who are urged to make this a priority.